| Style | Citing Format |
|---|---|
| MLA | Nowroozi A, Rezaei N. "Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?." Infection Control and Hospital Epidemiology, vol. 43, no. 11, 2022, pp. 1754-1755. |
| APA | Nowroozi A, Rezaei N (2022). Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?. Infection Control and Hospital Epidemiology, 43(11), 1754-1755. |
| Chicago | Nowroozi A, Rezaei N. "Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?." Infection Control and Hospital Epidemiology 43, no. 11 (2022): 1754-1755. |
| Harvard | Nowroozi A, Rezaei N (2022) 'Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?', Infection Control and Hospital Epidemiology, 43(11), pp. 1754-1755. |
| Vancouver | Nowroozi A, Rezaei N. Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?. Infection Control and Hospital Epidemiology. 2022;43(11):1754-1755. |
| BibTex | @article{ author = {Nowroozi A and Rezaei N}, title = {Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?}, journal = {Infection Control and Hospital Epidemiology}, volume = {43}, number = {11}, pages = {1754-1755}, year = {2022} } |
| RIS | TY - JOUR AU - Nowroozi A AU - Rezaei N TI - Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us? JO - Infection Control and Hospital Epidemiology VL - 43 IS - 11 SP - 1754 EP - 1755 PY - 2022 ER - |